A potential therapeutic target for colon cancer

May 10, 2010

A research team from China investigated the association between peroxisome proliferator-activated receptor-γ (PPAR-γ) gene polymorphism 34 C>G and colorectal cancer (CRC) through a meta-analysis. They found PPAR-γ 34 C>G is associated with colon cancer risk, but not associated with CRC and rectal cancer risk.

Colorectal cancer (CRC) is one of the major causes of cancer death in the developed countries. Accumulated evidences indicate that lipid metabolism, especially the one in the arachidonic acid (AA)-pathway, appears to play a critical role in the development of CRC. The peroxisome proliferator-activated receptor-γ(PPAR-γ) gene, one of the most important components of the AA-pathway, has been verified to express in a variety of tumor cells. Many studies have been performed about the association between the polymorphism 34 C>G of PPAR-γgene and CRC, but got conflicting results.

A research article to be published on May 7, 2010 in the World Journal of Gastroenterology addresses this question. A research team led by Professor Li-Cheng Dai, confirmed the former data of the association between PPAR-γgene 34 C>G and CRC in the meta-analysis.

In this report, the association between PPAR-γ gene 34 C>G and colon cancer risk was observed, and the G allele decreased the colon cancer risk, which is meaningful to early diagnosis, prevention and individual-based treatment of colon cancer. Furthermore, 34 C>G of PPAR-γ gene might be a potential therapeutic target for .

Explore further: Discovery could lead to new cancer treatment

More information: Lu YL, Li GL, Huang HL, Zhong J, Dai LC. Peroxisome proliferator-activated receptor-γ 34C>G polymorphism and colorectal cancer risk: A meta-analysis. World J Gastroenterol 2010; 16(17): 2170-2175 www.wjgnet.com/1007-9327/full/v16/i17/2170.htm

add to favorites email to friend print save as pdf

Related Stories

Defective signaling pathway sheds light on cystic fibrosis

Feb 14, 2010

In a study that could lead to new therapeutic targets for patients with the cystic fibrosis, a research team from the University of California, San Diego School of Medicine has identified a defective signaling pathway that ...

A potential drug for liver carcinoma

May 22, 2009

Looking for efficient anti-tumor drugs is a hot research area. Chrysin (5,7-dihydroxy flavone), a natural widely-distributed flavonoid, has been reported to have many different biological activities such as anti-oxidant, ...

Smoking can double risk of colorectal polyps

Feb 01, 2008

Smokers have a two-fold increased risk of developing colorectal polyps, the suspected underlying cause of most colorectal cancers (CRC), according to a study published in Gastroenterology, the official journal of the Americ ...

Recommended for you

Discovery could lead to new cancer treatment

Aug 29, 2014

A team of scientists from the University of Colorado School of Medicine has reported the breakthrough discovery of a process to expand production of stem cells used to treat cancer patients. These findings could have implications ...

Is the HPV vaccine necessary?

Aug 29, 2014

As the school year starts in full swing many parents wonder if their child should receive the HPV vaccine, which is recommended for girls ages 11-26 and boys 11-21. There are a lot of questions and controversy around this ...

User comments : 0